Not rendering correctly? View this email as a web page here.

Q4 2018


CLSI Year in Review

Read More


  • FAST 2018 Fall Closing Showcase Celebrates Seven Companies | Read More
  • Meet with Representatives of JT Pharma | Read More
  • CLSI and the Canadian Technology Accelerator Program Partner in assisting Emerging Canadian Life Science Companies | Read More
  • FAST grad (Fall 2017) Pheronym is named winner of the Sacramento Region Innovation Award in Food and Agribusiness | Read More  Watch video presentation here
  • Watch FAST grad (Fall 2017) Inflammatix’s TED Talk on Immune Profiling: A New Way to Diagnose Infections | Watch Here
  • FAST grad (Spring 2017) HepaTx’s President and CEO, Eric Schuur discusses how HepaTx came about and how his work will benefit people with liver disease | Read More
  • FAST grad (Spring 2016) Eidos Therapeutics announced the FDA has granted orphan drug designation for AG10, for the treatment of transthyretin amyloidosis | Read More
  • FAST grad (Spring 2016) Paragon Genomics announced introduction of CleanPlex® UMI Lung Cancer Panel, which can detect highly accurate low-frequency variants and mutations for liquid biopsies. The company also announced they have entered a partnership with SOPHiA GENETICS , a leader in Data-Driven Medicine to incorporate their CleanPlex® NGS target enrichment technologies into the SOPHiA AI Platform to be used in 850 hospitals in 72 countries | Read More
  • FAST grad (Spring 2015) Magnetic Insight announced they raised $18M Series A led by 5AM Ventures to support commercial growth of magnetic particle imaging in cell therapy, vascular and oncology | Read More

About FAST Advisory Program

The FAST Advisory Program provides select entrepreneurs with intensive team review and coaching to perfect their business model, product development plans, and to build a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement and business development specialists) will advise selected Fellows during a twelve-week program, culminating in a Final FAST Showcase to a broad audience that includes potential investors and partners.

For information on the FAST program, contact Julie Harness at

Upcoming Events & Key Dates
12/14 Application Deadline to Pitch at RESI JPM, San Francisco Register Here


Deadline to apply for San Diego Angel Conference: Application for Entrepreneurs, San Diego Register Here
1/5 Innovations in Regulatory Science Summit, San Francisco Register Here
1/6 Pre-JPM CTIC Healthcare Investment Summit, San Francisco (20% discount code before 12/15: CLSI19) Register Here
1/7-9 Biotech Showcase 2019, San Francisco Register Here
1/7-9 Digital Medicine & Medtech Showcase, San Francisco Register Here
1/8 RESI San Francisco Conference 2019(Registration $750 for Tech Hub Constituents, use code “RESIJPMTHC”)  Register Here
1/8 WuXi Global Forum 2019 and Reception – A Celebration of Global Partnerships, San Francisco Register Here
1/15 FAST & Fellows Networking Happy Hour, South San Francisco Register Here
1/15 Deadline to apply for MedCity INVEST Pitch Perfect held April 23-24, Chicago Register Here
1/15 QB3 Seminar: Success in the Foodtech Space at Ripple, San Francisco Register Here
1/20-23 Precision Medicine World Conference 2019, Santa Clara Register Here


JLABS: Start with the End in Mind - Healthcare Market Access in the Digital Age, South San Francisco Register Here
1/24 JLABS: Who’s Who in 2019: Where the 2018 Healthcare Innovation investing wave broke? South San Francisco Register Here
1/25 Deadline to apply for Spring 2019 FAST Program Apply Here
1/29 Rosenman Institute: How to Adapt to a Changing Market Environment, San Francisco Register Here
1/31 QB3 Seminar: Jennifer Doudna, UC Berkeley & Caribou Bio, San Francisco Register Here
2/6-8 DataAI National Summit 2019 (DANS2019) Silicon Valley Register Here
2/7 QB3 Seminar: Tackling Novel Drug Targets at a Virtual Startup, San Francisco Register Here
2/21 JLABS: Meet with The Novartis Biome, South San Francisco Register Here
3/3-5 Festival of Biologics San Diego Register Here
3/19 JLABS: Meet with Bioverge, South San Francisco Register Here



  • CARB-X 2017-18 Annual Report: Progress Against Superbugs | Read Here
  • CARB-X calls for new ‘open science’ era in antibacterial innovation: Sharing scientific data will help speed the delivery of new antibiotics and other life-saving products to fight superbugs | Read More
  • Powered by CARB-X company, Summit Therapeutics discovered multiple new mechanism antibiotics to treat “superbug” pathogens using its Discuva platform | Read More
  • Powered by CARB-X company, MicuRx announced receipt of FDA’s QIDP and Fast Track designations for contezolid for the treatment of acute bacterial skin and skin structure infections | Read More
  • Powered by CARB-X company, Vedanta Biosciences’ CEO Bernat Olle shares a recap of a recent FDA NIH workshop discussing the need for regulatory oversight for microbiome drug developers | Read More
  • Powered by CARB-X company, Spero Therapeutics was granted Qualified Infectious Disease Product (QIDP) designation for SPR206, a product candidate for the treatment of complicated urinary tract infectious | Read More

 About CARB-X


CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With more than $500 million to invest, CARB-X funds the best science from around the world. The CARB-X portfolio is the world’s largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent and treat life-threatening bacterial infections. CARB-X operates through Boston University. Other partners include RTI International, the Broad Institute of Harvard and MIT, MassBio, and the California Life Sciences Institute (CLSI).

For more information on CARB-X, please contact Amy Xu at

Upcoming Events
12/13  GARDP Making Safety a Part of Drug Design Webinar Register Here
12/13 New Strategies in Antibiotic Drug Development Webinar More Info
1/15  Antimicrobial Chemotherapy Conference 2019, London Register Here
2/4-5  Hamied Foundation UK-India Antimicrobial Resistance Meeting 2019, London Register Here
3/14-15  Berlin Conference On Life Sciences: Novel Antimicrobials and AMR Diagnostics 2019, Berlin Register Here
3/21-22  British Society for Antimicrobial Chemotherapy Spring Conference 2019, Birmingham Register Here
3/26  The Economist 1 Day Symposium: “Antimicrobial Resistance: Preventing an Antibiotic Apocalypse”, London Register Here
4/13-16 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2019, Amsterdam Register Here
4/24-26  The Society for Healthcare Epidemiology of America (SHEA) Spring 2019 Conference, Boston Register Here
6/20-24  ASM Microbe 2019, San Francisco Register Here
9/3-6  ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, Boston Register Here
10/2-6  IDWeek 2019, Washington DC Register Here
10/19-27  International Course on Antibiotics and Resistance, Annecy, France Register Here


 STEM Education & Careers 

  • CLSI Partners on Coming Age of Genomics Documentary | Read More 
  • Speed Networking Brings Students and Industry Volunteers Together | Read More
  • CLSI Presents Workforce Trends Data at Legislative Briefing | Read More 
  • CSweetener: Executive Mentoring for Women | Read More 
  • Empowering Bay Area Teen Science Startups | Read More
  • Guest Article: Genetics Society for America Seeking Mentors for CA PhDs | Read More
  • Biotech Primer Article: CRISPR Babies | Read More

About CLSI Education & Career Programs

CLSI helps build the next generation of life science professionals by bringing industry and institutions of learning together to improve STEM education in California and to inspire and develop life science careers. CLSI also works to ensure that the current and anticipated talent needs of the industry are met, and that the workforce pipeline for the industry remains strong.

Upcoming Events
12/13-14 BioBasics: Biotech For The Non-Scientist, South San Francisco Register Here
1/25-26 UC San Diego Extension: MCLE – Technology Licensing Workshop, San Diego Register Here
2/4 CLSA: Leadership EDGE for Women, South San Francisco Register Here
2/11-15 UCSF Department of Bioengineering and Therapeutic Sciences: Pharmacokinetics for Pharmaceutical Scientists Course, South San Francisco Register Here
3/4 CLSA: Leadership EDGE for Women, South San Francisco Register Here
3/14 The ART of Inclusive Communication, San Diego Register Here
3/21-5/2 (Four Days) From Laboratory to Leadership – 25th Anniversary Edition, South San Francisco Register Here
4/1 Leadership EDGE for Women, South San Francisco Register Here



California Life Sciences Institute (CLSI) supports the foundations of innovation that have made California home to the world’s most prominent life sciences ecosystem. Our mission is to maintain California’s leadership in life sciences innovation through support of entrepreneurship, education and career development. CLSI also serves as an accelerator for CARB-X, the world’s largest public-private partnership devoted to early stage antibacterial R&D.

CLSI is an affiliate of the California Life Sciences Association (CLSA), which represents California’s leading life sciences organizations. The California Life Sciences Institute is a non-profit 501(c)(3), and was established in 1990 as the BayBio Institute.